Instructions for Cerpehol (choline alfoscerate) 600 mg
Cerpehol (choline alfoscerate) 600 mg
Instructions for use Cerpehol
Choline Alfoscerate - 600 mg.
Description
Choline Alfoscerate - 600 mg.
The drug is a transparent solution that may be colorless or slightly yellowish. It has a faint characteristic odor.
Choline Alfoscerate - 600 mg.
Active Components
The main active ingredient is choline alfoscerate.
Choline Alfoscerate - 600 mg.
Release Form
Choline Alfoscerate - 600 mg.
Excipients Cerpehol:
methylparahydroxybenzoate - 8 mg, propyl parahydroxybenzoate - 2.4 mg,
sodium saccharinate - 3 mg,
purified water - up to 7 ml.
Mechanism of action
Choline alfoscerate is a nootropic agent acting as a central cholinomytic. It improves memory, cognition, emotional state, and behavior, which is particularly important in age-related changes in the brain. The drug contains 40.5% metabolically stable choline.
After ingestion of choline, alfoscerate is degraded to choline and glycerophosphate by enzymes. Choline is involved in the synthesis of acetylcholine, a key neurotransmitter. Glycerophosphate is the precursor of phosphatidylcholine, an important component of neuronal membranes.
Thanks to these processes of choline alfoscerate:
Increases the efficiency of nerve impulse transmission in cholinergic neurons.
Improves the flexibility of neuronal membranes.
It has a positive effect on the function of receptors.
Indications for use Cerpehol:
Psychoorganic syndrome associated with age-related changes and degenerative processes in the brain.
It is also used to treat the consequences of cerebrovascular and primary or secondary cognitive impairment in older adults.
The main symptoms include memory impairment,
confusion, confusion,
loss of motivation and initiative, and impaired ability to concentrate.
The drug is also used to treat behavioral and emotional disturbances in older adults, such as emotional instability, increased irritability, and decreased interest in the world around them. It is also effective in senile pseudomelancholy and multiinfarct dementia.